Latest news with #RedwoodCity
Yahoo
6 days ago
- Business
- Yahoo
Zilliz Introduces Zero-Downtime Migration Services for Seamless Unstructured Data & Vector Embeddings Transfers
New solutions eliminate friction, enabling effortless portability of unstructured data and embeddings across systems — with no downtime, no vendor lock-in, and no added cost. REDWOOD CITY, Calif., May 29, 2025 /CNW/ -- Zilliz, creator of the world's most widely adopted open-source vector database, Milvus, introduced a powerful new set of Migration Services designed to make moving unstructured data and vector embeddings between platforms fast, reliable, and cost-free. These solutions eliminate the technical and operational barriers that typically slow down AI data infrastructure modernization. "Organizations working with unstructured data for AI applications face migration challenges that traditional ETL pipelines simply can't solve," said James Luan, VP of Engineering at Zilliz. "Our new tools provide the missing infrastructure layer — making it easy to migrate from Elasticsearch to Milvus, consolidate across multiple vector stores, or move to Zilliz Cloud with zero disruption." Breaking Down Migration Barriers for Unstructured Data Unstructured data — including images, text, audio, and video — now accounts for over 90% of enterprise data. As organizations turn this data into vector embeddings, they run into major roadblocks: Format Variety: Unstructured data exists in diverse formats (JSON, CSV, Parquet, images, etc.), requiring specialized processing System Fragmentation: Business information is scattered across S3, HDFS, Kafka, data warehouses, and data lakes Vendor Lock-in Risks: Moving vector embeddings between databases often creates technical dependencies and potential vendor lock-in Complex Transformations: Converting unstructured data requires AI model integration for embedding generation and schema mapping Two Flexible Options for Every Environment Zilliz offers Migration Services that directly respond to these challenges through two complementary deployment options: Zilliz Migration Service provides a free, fully managed solution with zero configuration requirements and zero downtime. This service handles all aspects of migration while maintaining continuous synchronization between source and target systems. Vector Transport Service (VTS), available as open-source software, offers the same capabilities for organizations that require self-hosted deployments in secure or air-gapped environments. Purpose-Built for AI and Vector Workloads Both solutions deliver essential features specifically designed for unstructured data and vector embeddings: Zero-Downtime Migrations: Continuous synchronization keeps applications running seamlessly during transitions Broad Source Compatibility: Support for Elasticsearch, Pinecone, Qdrant, PostgreSQL, Milvus, and more Flexible Migration Modes: Options for one-time batch imports or real-time streaming synchronization Purpose-Built for Unstructured Data and Vector Embeddings: Specialized handling with schema mapping and transformations Enterprise-Grade Reliability: Designed for massive datasets with robust monitoring and alerting Empowering Data Freedom Across Industries Organizations across sectors are already using Zilliz Migration Services to transform their AI infrastructure: A global retailer migrated 200 million product embeddings from Elasticsearch to Zilliz Cloud, improving search accuracy by 40% while cutting infrastructure costs in half A healthcare organization moved patient data vectors between systems while maintaining strict HIPAA compliance A financial services provider eliminated vendor dependency by moving to an open-source foundation while maintaining continuous operation "Migrating between platforms without rebuilding pipelines from scratch is a game-changer for our AI strategy," said one customer. "What would have taken months of engineering was completed in days, allowing us to focus on innovation rather than infrastructure management." Availability Zilliz's new migration solutions are now generally available: Zilliz Migration Service: Available as a free, fully managed service within Zilliz Cloud Vector Transport Service: Available as open-source software under the Apache 2.0 license at For more information about Zilliz Migration Services, visit or contact support. About Zilliz Zilliz is an American SaaS company that builds next-generation vector database technologies, helping organizations unlock the value of unstructured data and rapidly develop AI and machine learning applications. By simplifying complex data infrastructure, Zilliz brings the power of AI within reach for enterprises, teams, and individual developers alike. Zilliz offers a fully managed, multi-cloud vector database service powered by open-source Milvus, supporting major cloud platforms such as AWS, GCP, and Azure, and is available across more than 20 countries and regions. Headquartered in Redwood Shores, California, Zilliz is backed by leading investors including Aramco's Prosperity7 Ventures, Temasek's Pavilion Capital, Hillhouse Capital, 5Y Capital, Yunqi Partners, Trustbridge Partners, and others. SOURCE zilliz View original content: Sign in to access your portfolio
Scottish Sun
26-05-2025
- Entertainment
- Scottish Sun
Watch the sweet moment Ruth Jones reunites with Neil the Baby after Gavin and Stacey finale
Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) GAVIN and Stacey fans were given a surprise treat across the weekend with a sweet mother-son reunion live on stage. At In It Together Festival in Port Talbot, Ruth Jones made an appearance on stage much to the delight of the bank holiday revellers. 6 Oscar and Ruth had a sweet reunion on stage Credit: Cover Images 6 Ruth beamed as she appeared on stage with Oscar Hartland, who plays Neil Credit: Cover Images Coming on stage to introduce a mystery guest, Ruth – famed for playing Nessa Shanessa Jenkins on the BBC favourite – managed to get an extra surprise in herself. Walking on to the Gavin and Stacey theme song Run by Stephen Fretwell, Ruth beamed as the crowd screamed for her after a countdown. She blew kisses to the audience before the Porthcawl native switched into Nessa mode, belting out her iconic 'Ohhhh, what's occurrin'?' Ruth then joked 'I don't really speak like that you know', putting on a mock posh voice. But the best was yet to come when she brought out on stage Neil The Baby – reuniting with her on-screen son (played by Oscar Hartland). The young musician was already performing at the festival with his band Redwood City, but swung by the main stage in order to give fans a treat alongside his fake mum. The pair shared an adorable hug on stage as he ran at her with his arms wife open, swooping her in for a cuddle. 'My son!' she beamed. 'Are you singing? Isn't he amazing! He takes after his mother, he does.' Oscar egged on the crowd, saying hello to them and encouraging them to cheer. She ended her stint on stage by answering a question about the infamous and mysterious events of the Gavin and Stacey fishing trip, joking: 'I don't know, I wasn't there!' The quick stint on stage ended with the introduction of The Greatest Showman star Keala Settle. In It Together Festival is a family event in Port Talbot, with Kaiser Chiefs, Becky Hill and Ronan Keating coming on stage as this year's headliners. The sweet moment comes just five months after the official end of Gavin and Stacey, which ended the tale of the Billericay and Barry collective. 6 Ruth beamed alongside her on-screen son Credit: Cover Images 6 Neil the Baby was the son of Nessa and Smithy's awkward one night stand Credit: Planet Photos In the final episode - which was watched by 19million people - fans finally saw Neil the Baby's parents, Nessa and Smithy (played by James Corden) tie the knot, with the family all getting their happy ending on Christmas Day. She later picked up a Bafta for the finale episode for her portrayal of the bolshy truck driver and arcade manager. After the win, Ruth teased that she and James Corden - who co-created and wrote Gavin and Stacey with her - could be set for something new. She said: 'I love working with James Corden, I really do, and I hope that we will carry on working together. 'I think we will. We will, because we just both, like, sort of sitting in a room together. We do a lot of napping, but we do write as well when we get going and, yeah, I just love working with him.' In the meantime, she's set to star in new Netflix drama, Run Away, which is currently being filmed. 6 Ruth is beloved as Nessa Jenkins Credit: BBC
The Sun
26-05-2025
- Entertainment
- The Sun
Watch the sweet moment Ruth Jones reunites with Neil the Baby after Gavin and Stacey finale
GAVIN and Stacey fans were given a surprise treat across the weekend with a sweet mother-son reunion live on stage. At In It Together Festival in Port Talbot, Ruth Jones made an appearance on stage much to the delight of the bank holiday revellers. 6 6 Coming on stage to introduce a mystery guest, Ruth – famed for playing Nessa Shanessa Jenkins on the BBC favourite – managed to get an extra surprise in herself. Walking on to the Gavin and Stacey theme song Run by Stephen Fretwell, Ruth beamed as the crowd screamed for her after a countdown. She blew kisses to the audience before the Porthcawl native switched into Nessa mode, belting out her iconic 'Ohhhh, what's occurrin'?' Ruth then joked 'I don't really speak like that you know', putting on a mock posh voice. But the best was yet to come when she brought out on stage Neil The Baby – reuniting with her on-screen son (played by Oscar Hartland). The young musician was already performing at the festival with his band Redwood City, but swung by the main stage in order to give fans a treat alongside his fake mum. The pair shared an adorable hug on stage as he ran at her with his arms wife open, swooping her in for a cuddle. 'My son!' she beamed. 'Are you singing? Isn't he amazing! He takes after his mother, he does.' Oscar egged on the crowd, saying hello to them and encouraging them to cheer. She ended her stint on stage by answering a question about the infamous and mysterious events of the Gavin and Stacey fishing trip, joking: 'I don't know, I wasn't there!' The quick stint on stage ended with the introduction of The Greatest Showman star Keala Settle. In It Together Festival is a family event in Port Talbot, with Kaiser Chiefs, Becky Hill and Ronan Keating coming on stage as this year's headliners. The sweet moment comes just five months after the official end of Gavin and Stacey, which ended the tale of the Billericay and Barry collective. 6 6 In the final episode - which was watched by 19million people - fans finally saw Neil the Baby's parents, Nessa and Smithy (played by James Corden) tie the knot, with the family all getting their happy ending on Christmas Day. She later picked up a Bafta for the finale episode for her portrayal of the bolshy truck driver and arcade manager. After the win, Ruth teased that she and James Corden - who co-created and wrote Gavin and Stacey with her - could be set for something new. She said: 'I love working with James Corden, I really do, and I hope that we will carry on working together. 'I think we will. We will, because we just both, like, sort of sitting in a room together. We do a lot of napping, but we do write as well when we get going and, yeah, I just love working with him.' In the meantime, she's set to star in new Netflix drama, Run Away, which is currently being filmed. 6 6
The Irish Sun
26-05-2025
- Entertainment
- The Irish Sun
Watch the sweet moment Ruth Jones reunites with Neil the Baby after Gavin and Stacey finale
GAVIN and Stacey fans were given a surprise treat across the weekend with a sweet mother-son reunion live on stage. At In It Together Festival in Port Talbot, Ruth Jones made an appearance on stage much to the delight of the bank holiday revellers. Advertisement 6 Oscar and Ruth had a sweet reunion on stage Credit: Cover Images 6 Ruth beamed as she appeared on stage with Oscar Hartland, who plays Neil Credit: Cover Images Coming on stage to introduce a mystery guest, Ruth – famed for playing Nessa Shanessa Jenkins on the BBC favourite – managed to get an extra surprise in herself. Walking on to the Gavin and Stacey theme song Run by Stephen Fretwell, Ruth beamed as the crowd screamed for her after a countdown. She blew kisses to the audience before the Porthcawl native switched into Nessa mode, belting out her iconic 'Ohhhh, what's occurrin'?' Ruth then joked 'I don't really speak like that you know', putting on a mock posh voice. Advertisement READ MORE GAVIN AND STACEY But the best was yet to come when she brought out on stage Neil The Baby – reuniting with her on-screen son (played by Oscar Hartland). The young musician was already performing at the festival with his band Redwood City, but swung by the main stage in order to give fans a treat alongside his fake mum. The pair shared an adorable hug on stage as he ran at her with his arms wife open, swooping her in for a cuddle. 'My son!' she beamed. 'Are you singing? Isn't he amazing! He takes after his mother, he does.' Advertisement Most read in TV Oscar egged on the crowd, saying hello to them and encouraging them to cheer. She ended her stint on stage by answering a question about the infamous and mysterious events of the Gavin and Stacey fishing trip, joking: 'I don't know, I wasn't there!' The quick stint on stage ended with the introduction of The Greatest Showman star Keala Settle. In It Together Festival is a family event in Port Talbot, with Kaiser Chiefs, Becky Hill and Ronan Keating coming on stage as this year's headliners. Advertisement The sweet moment comes just five months after the official end of Gavin and Stacey, which ended the tale of the Billericay and Barry collective. 6 Ruth beamed alongside her on-screen son Credit: Cover Images 6 Neil the Baby was the son of Nessa and Smithy's awkward one night stand Credit: Planet Photos In the final episode - which Advertisement She After the win, Ruth teased that she and James Corden - who co-created and wrote Gavin and Stacey with her - could be set for something new. She said: 'I love working with James Corden, I really do, and I hope that we will carry on working together. 'I think we will. We will, because we just both, like, sort of sitting in a room together. We do a lot of napping, but we do write as well when we get going and, yeah, I just love working with him.' Advertisement In the meantime, she's set to star in new Netflix drama, Run Away, which is currently being filmed. 6 Ruth is beloved as Nessa Jenkins Credit: BBC 6 The beloved series ended on Christmas Day 2024 Credit: PA
Associated Press
19-05-2025
- Business
- Associated Press
Juvena Therapeutics Announces Initiation of First-in-Human Clinical Trial of JUV-161
REDWOOD CITY, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- Juvena Therapeutics, Inc. ('Juvena'), a clinical-stage biotechnology company pioneering tissue restorative biologics for chronic muscle and metabolic diseases, announced today that it is enrolling participants into its clinical trial evaluating JUV-161, a first-in-class fusion protein that enhances muscle regeneration through its pro-myogenic, insulin-resistance modulating, and anti-inflammatory properties. JUV-161 is a muscle regenerating endocrine therapy being investigated for the treatment of Myotonic Dystrophy Type 1 (DM1) and Sarcopenia. JUV-161 received FDA Orphan Disease Drug designation for DM1 in 2024. 'JUV-161 is a natural, endocrine protein therapy that will help restore critical protein signaling in diseased muscle to more youthful, healthy levels, so that we can restore muscle health and ultimately restore the quality of life of individuals living with many indications where muscle loss reduces the quality of life or lifespan,' said CEO and co-founder of Juvena Therapeutics, Dr. Hanadie Yousef. 'JUV-161 is a unique tissue restorative therapy that is different from other anti-sense, RNA-targeting, or gene therapy knockdown approaches currently being taken for DM1.' 'As the world's largest myotonic dystrophy patient advocacy organization, founded by families impacted by DM and supporting research toward treatments and cures, the Myotonic Dystrophy Foundation is super excited about Juvena Therapeutics' lead candidate, JUV-161, entering the clinical testing phase with a truly novel approach,' said Myotonic Dystrophy Foundation, Chief Science Officer, Dr. Andy Rohrwasser. 'This milestone is great news for myotonic dystrophy (DM) families because JUV-161 targets muscle regeneration and metabolism to improve overall muscle function and health and has the potential to improve and restore muscle.' 'With JUV-161, we're thrilled to bring to the clinic the first asset emerging from our JuvNET platform which deconvolutes human stem cell secretome biology with a combination of quantitative proteomics and AI,' said Dr. Jeremy O'Connell, Chief Scientific Officer and co-founder of Juvena Therapeutics. 'As we continue to unlock the therapeutic potential of a proven yet understudied source of biologics, Juvena is poised to identify life-changing muscle regenerative and pro-metabolic therapies in high demand across disease categories.' About the Study Juvena has received approval from Australia's Human Research Ethics Committees (HREC) to commence the study and is now enrolling participants. The first-in-human, single-ascending dose study is evaluating the safety, tolerability and pharmacokinetics and pharmacodynamics of JUV-161 in healthy adult volunteers. The trial is part of the company's global clinical 'pipeline in a product' strategy. Testing in healthy volunteers will enable Juvena to expand to multiple potential muscle disease indications in the near future. Next year, Juvena expects to submit an Investigational New Drug (IND) application for JUV-161 and to initiate two Phase II studies in people living with congenital DM1 and sarcopenia. To learn more about the study visit About DM1 Today, there are no FDA-approved therapeutics for DM1, a progressive, multi-systemic, inherited autosomal dominant genetic disease that causes muscle degeneration, with weakness and shrinkage of the muscle tissue, myotonia, heart abnormalities, cataracts and insulin resistance, amongst other symptoms. An estimated one in 2,100 people, or over 3.6 million individuals globally, have DM1, representing a major unmet medical need.123 About JUV-161 Often referred to as a potential 'insulin for muscle,' JUV-161 modulates muscle regeneration and metabolism, enhancing overall muscle health. The fusion protein has demonstrated a unique ability to restore muscle fiber formation, counter muscle atrophy, enhance muscle strength and endurance, and improve muscle metabolism in multiple preclinical disease models ranging from models of dystrophies to models of sarcopenia resulting from aging, obesity, diabetes, and inflammation. The long-lasting investigational biologic acts by activating and restoring AKT signaling, a pathway that regulates cell survival, growth, and metabolism, and is often dysregulated in muscle-wasting diseases and as people naturally age. Identified by Juvena's AI-driven drug discovery and development platform, JuvNET, JUV-161's primary mechanism of action is derived from an engineered human Insulin-like Growth Factor 2 (IGF2) protein developed for subcutaneous injection. About JuvNET: A Unique AI-driven Discovery Platform Mapping the Therapeutic Potential of Secreted Proteins JUV-161 is the lead therapeutic candidate discovered by JuvNET, which screens Juvena's proprietary protein library of human stem-cell secreted proteins with therapeutic potential using unbiased quantitative proteomics, multi-omics and high-content imaging data, combined with a variety of artificial intelligence technologies. The company's pipeline of biologics for myopathies and metabolic diseases, all produced by JuvNET, include JUV-112, an obesity targeting biologic which induces fat and weight loss via a non-appetite suppressive, muscle sparing, energy expenditure inducing mechanism. Additionally, Juvena's platform has identified over 50 secreted protein hits to date across multiple metabolic diseases and organ systems. About Juvena Therapeutics Juvena Therapeutics is a platform-driven, clinical-stage company unlocking the therapeutic potential of stem-cell secreted proteins and translating them into a growing pipeline of engineered biologics for chronic muscle and metabolic diseases. Juvena is achieving this through its fully integrated, end-to-end Artificial Intelligence (AI)-enabled drug discovery and development platform, JuvNET, that combines a compounding database mapping secreted proteins to specific disease phenotypes, in silico and in vitro human cell screening, pharmacology, and protein engineering capabilities. In addition to a pipeline of biologic drug candidates spanning chronic muscle and obesity-related diseases, the company has generated dozens of hits with tissue restorative benefits spanning pulmonary and hepatic fibrosis and osteoarthritis. To learn more visit or follow the company on LinkedIn @Juvena-Therapeutics. Press Inquiries Shira Derasmo Cuttlefish Communications +1 917-280-2497 [email protected] ____________________________
